Sab Biotherapeutics Share Price Today
(NASDAQ: SABS)
Sab Biotherapeutics share price is $2.23 & ₹194.84 as on 5 Feb 2025, 2.30 'hrs' IST
$2.23
▲
0.08
(3.72%)
Market is closed - opens 8 PM, 05 Feb 2025
View live Sab Biotherapeutics share price in Dollar and Rupees. Guide to invest in Sab Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sab Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Sab Biotherapeutics share price movements
- Today's Low: $2.10Today's High: $2.28
5.83%
Downside
Day's Volatility :7.89%
Upside
2.19%
- 52 Weeks Low: $2.0052 Weeks High: $6.30
10.31%
Downside
52 Weeks Volatility :68.25%
Upside
64.6%
Sab Biotherapeutics (SABS) Returns
Sab Biotherapeutics (SABS) Key Statistics
in dollars & INR
How to invest in Sab Biotherapeutics Stock (SABS) from India?
It is very easy for Indian residents to invest directly in Sab Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sab Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sab Biotherapeutics or SABS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sab Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Sab Biotherapeutics shares which would translate to 0.392 fractional shares of Sab Biotherapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sab Biotherapeutics, in just a few clicks!
Returns in Sab Biotherapeutics (SABS) for Indian investors in Rupees
The Sab Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
Investment Value
₹1,00,000
Sab Biotherapeutics investment value today
Current value as on today
₹45,560
Returns
Returns from Sab Biotherapeutics Stock
Dollar Returns
₹5,235 (+5.23%)
Indian investors sentiment towards Sab Biotherapeutics (SABS)
Global Institutional Holdings in Sab Biotherapeutics
Bvf Inc
9.94%
RTW INVESTMENTS, LLC
6.88%
Marshall Wace Asset Management Ltd
4.98%
Sessa Capital IM LP
4.97%
Vanguard Group Inc
2.99%
HB Wealth Management, LLC
2.57%
Analyst Recommendation on Sab Biotherapeutics
Buy
87%Buy
12%Hold
0%Sell
Based on 8 Wall street analysts offering stock ratings for Sab Biotherapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Sab Biotherapeutics Stock (SABS)
What analysts predicted
Upside of 527.8%
Target:
$14.00
Current:
$2.23
Insights on Sab Biotherapeutics Stock (Ticker Symbol: SABS)
Price Movement
In the last 1 month, SABS stock has moved down by -39.1%Decreasing Revenue
Revenue is down for the last 2 quarters, 944.57K → 263.13K (in $), with an average decrease of 72.1% per quarterDecreasing Net Profit
Netprofit is down for the last 3 quarters, -5.02M → -10.34M (in $), with an average decrease of 43.5% per quarterSABS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 118.5%SABS vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 86.4% return, outperforming this stock by 182.5%Price to Sales
ForSABS every $1 of sales, investors are willing to pay $12.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.4 for every $1 of sales.
Sab Biotherapeutics Technicals Summary
Sell
Neutral
Buy
Sab Biotherapeutics is currently in a neutral trading position according to technical analysis indicators.
Sab Biotherapeutics (SABS) Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -36.65% | -16.01% | -59.67% | -95.85% | -96.95% |
 | -2.55% | 47.81% | 22.02% | -32.21% | 279.34% |
 | -2.68% | -34.72% | -25.67% | 12.0% | 82.54% |
 | 19.82% | 3.52% | 15.9% | 98.26% | 100.9% |
 | 16.23% | 4.16% | 57.39% | 82.31% | 115.97% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -3.64 | -1.75 | -0.79 | NA | 4.0 |
| 160.8 | NA | 0.04 | -3.37 | -0.02 | -0.01 | NA | 79.73 |
| 16.49 | 16.49 | 1.08 | 44.92 | 0.17 | 0.07 | NA | 272.04 |
| 32.84 | NA | 1.21 | 0.48 | -0.03 | 0.12 | NA | 60.65 |
| NA | NA | -0.49 | -0.18 | -15.01 | -0.03 | NA | 0.25 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $19.8M | -96.95% | NA | 0.0% |
| Buy | $28.7B | 279.34% | 160.8 | -15.36% |
| Buy | $73.3B | 82.54% | 16.49 | 33.61% |
| Buy | $121.1B | 100.9% | 32.84 | -4.51% |
| Buy | $35.4B | 115.97% | NA | -15.86% |
About Sab Biotherapeutics
Management People of Sab Biotherapeutics
Important FAQs about investing in SABS Stock from India :
What is Sab Biotherapeutics share price today?
Sab Biotherapeutics share price today stands at $2.23, Open: $2.10 ; Previous Close: $2.15 ; High: $2.28 ; Low: $2.10 ; 52 Week High: $6.30 ; 52 Week Low: $2.00.
The stock opens at $2.10, after a previous close of $2.15. The stock reached a daily high of $2.28 and a low of $2.10, with a 52-week high of $6.30 and a 52-week low of $2.00.
Can Indians buy Sab Biotherapeutics shares?
Yes, Indians can invest in the Sab Biotherapeutics (SABS) from India.
With INDmoney, you can buy Sab Biotherapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Sab Biotherapeutics at zero transaction cost.
How can I buy Sab Biotherapeutics shares from India?
It is very easy to buy Sab Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Sab Biotherapeutics (SABS) be purchased?
Yes, you can buy fractional shares of Sab Biotherapeutics with INDmoney app.
What are the documents required to start investing in Sab Biotherapeutics stocks?
To start investing in Sab Biotherapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Sab Biotherapeutics Stock (SABS)?
Today’s highest price of Sab Biotherapeutics (SABS) is $2.28.
Today’s lowest price of Sab Biotherapeutics (SABS) is $2.10.
What is today's market capitalisation of Sab Biotherapeutics?
What is the 52 Week High and Low Range of Sab Biotherapeutics Stock (SABS)?
52 Week High
$6.30
52 Week Low
$2.00
What are the historical returns of Sab Biotherapeutics (SABS)?
1 Month Returns
-36.65%
3 Months Returns
-16.01%
1 Year Returns
-59.67%
5 Years Returns
-96.95%
Who is the Chief Executive Officer (CEO) of Sab Biotherapeutics ?
Discover More
Ioneer Ltd$4.44
+5.21%
Dakota Gold Corp$2.43
+5.65%
Spdr S&p 500 Fossil Fuel Reserves Free Etf$49.43
+0.69%
Invesco Bulletshares 2026 Municipal Bond Etf$23.71
+0.22%
- Proshares Decline Of The Ret
$12.75
-1.27%
Global X Msci Greece Etf$40.62
+1.65%
- Spyre Therapeutics Inc
$23.70
+3.49%
- Bny Mellon Dynamic Value Etf
$25.71
+0.16%
Yieldmax Amzn Option Income Strategy Etf$20.08
+1.47%